# LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/LMAT/lemaitre-to-present-at-the-24th-annual-needham-virtual-healthcare-conference-92b25998
Ticker: LMAT
Company: LeMaitre Vascular
Source: LeMaitre Vascular
Published: 2025-04-01 19:20 EST
## Summary

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th...

## Article Body
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
## Recent Company News
- 2026-07-14 21:43 EST — [LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-second-quarter-2026-earnings-results-on-august-4-2026-269755ae) — Source: LeMaitre Vascular
- 2026-05-20 20:25 EST — [LeMaitre to Participate at Upcoming Investor Conferences in June](https://biopharmsignal.com/news/LMAT/lemaitre-to-participate-at-upcoming-investor-conferences-in-june-a4d71e69) — Source: LeMaitre Vascular
- 2026-05-07 21:15 EST — [LeMaitre to Present at the Bank of America Healthcare Conference](https://biopharmsignal.com/news/LMAT/lemaitre-to-present-at-the-bank-of-america-healthcare-conference-3f9a75f1) — Source: LeMaitre Vascular
- 2026-05-05 20:05 EST — [LeMaitre Q1 2026 Financial Results](https://biopharmsignal.com/news/LMAT/lemaitre-q1-2026-financial-results-1a3119ae) — Source: LeMaitre Vascular
- 2026-04-14 20:54 EST — [LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026](https://biopharmsignal.com/news/LMAT/lemaitre-will-announce-first-quarter-2026-earnings-results-on-may-5-2026-b7240d53) — Source: LeMaitre Vascular
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)